相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor suppressive effect of lysyl oxidase proenzyme
Sara Contente et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Janine T. Erler et al.
CANCER CELL (2009)
Three-dimensional context regulation of metastasis
Janine T. Erler et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
The Lysyl Oxidase Pro-peptide Attenuates Fibronectin-mediated Activation of Focal Adhesion Kinase and p130Cas in Breast Cancer Cells
Yingshe Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation
Paola A. Hurtado et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis
Lars Johan Nissen et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells
Min Wu et al.
CANCER RESEARCH (2007)
Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells
Ying Guo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer
Chengyin Min et al.
CANCER RESEARCH (2007)
Lysyl oxidase mediates hypoxic control of metastasis
Janine T. Erler et al.
CANCER RESEARCH (2006)
Heparin affin regulatory peptide/pleiotrophin mediates fibroblast growth factor 2 stimulatory effects on human prostate cancer cells
Maria Hatziapostolou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells
Shlomit Erlich et al.
BIOCHEMICAL PHARMACOLOGY (2006)
被撤回的出版物: Lysyl oxidase is essential for hypoxia-induced metastasis (Retracted article. See vol. 579, pg. 456, 2020)
JT Erler et al.
NATURE (2006)
Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism
SL Payne et al.
CANCER RESEARCH (2005)
Real-time RT-PCR normalisation; strategies and considerations
J Huggett et al.
GENES AND IMMUNITY (2005)
The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling
K Forsten-Williams et al.
JOURNAL OF THEORETICAL BIOLOGY (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway
UV Wesley et al.
CANCER RESEARCH (2005)
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism
CL Chu et al.
BIOCHEMICAL JOURNAL (2004)
The novel ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro
RA McPherson et al.
PROSTATE (2004)
Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2
CC Chua et al.
CIRCULATION RESEARCH (2004)
The propeptide domain of lysyl oxidase induces phenotypic reversion of Ras-transformed cells
AH Palamakumbura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of fibroblast growth factors and their receptors in prostate cancer
B Kwabi-Addo et al.
ENDOCRINE-RELATED CANCER (2004)
Common and distinct elements in cellular signaling via EGF and FGF receptors
J Schlessinger
SCIENCE (2004)
Ras signaling in prostate cancer progression
MJ Weber et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3K/AKT activation
L Bonaccorsi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells
R Bansal et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts
AH Palamakumbura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice
QM He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lysyl oxidase inhibits Ras-mediated transformation by preventing activation of NF-κB
S Jeay et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell
HM Kagan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Partial characterization of endothelial FGF receptor functional domain by monoclonal antibody VBS-1
VD Blanckaert et al.
HYBRIDOMA AND HYBRIDOMICS (2002)
Role of fibroblast growth factor receptor signaling in prostate cancer cell survival
M Ozen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Interleukin-6 is an autocrine growth factor in human prostate cancer
D Giri et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin
JA Smith et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures
MI Uzel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Fibroblast growth factor-2
MA Nugent et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
分享论文
